Sanara MedTech (SMTI) Cash from Operations (2016 - 2025)
Sanara MedTech's Cash from Operations history spans 15 years, with the latest figure at 3945061.0 for Q4 2025.
- For Q4 2025, Cash from Operations rose 323.27% year-over-year to 3945061.0; the TTM value through Dec 2025 reached 6786629.0, up 28634.43%, while the annual FY2025 figure was 6786629.0, 28634.43% up from the prior year.
- Cash from Operations reached 3945061.0 in Q4 2025 per SMTI's latest filing, up from 2176441.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 3945061.0 in Q4 2025 to a low of 2112478.0 in Q1 2022.
- Average Cash from Operations over 5 years is 342605.35, with a median of 1207960.5 recorded in 2021.
- Peak YoY movement for Cash from Operations: tumbled 245.3% in 2022, then skyrocketed 323.27% in 2025.
- A 5-year view of Cash from Operations shows it stood at 1784358.0 in 2021, then surged by 63.85% to 645016.0 in 2022, then crashed by 31.55% to 848532.0 in 2023, then skyrocketed by 209.84% to 932047.0 in 2024, then surged by 323.27% to 3945061.0 in 2025.
- Per Business Quant, the three most recent readings for SMTI's Cash from Operations are 3945061.0 (Q4 2025), 2176441.0 (Q3 2025), and 2664011.0 (Q2 2025).